Celgene-CELG Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celgene-CELG

CELG 108.24

0.0%

Nov 22 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jesse Schulman who wrote (340)	9/8/1999 9:56:00 PM
From: Biomaven	of 804

ITSS, Imagine if CELG had an approved drug that had the promise of T - in fact was identical to T in all respects except its history. I think that CELG's market cap would be at least double what it is now. Thus the historical problems with T are already built into the stock price. These historical problems make people wary about the stock and also make doctors more wary about prescribing it. Certainly there is a small risk of another birth defect happening despite all the precautions, and this would certainly get some big time play. However T is being used for serious diseases, and I doubt it would have that much long term impact. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next